These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8941222)

  • 1. The human immunodeficiency virus.
    Hardy WD
    Med Clin North Am; 1996 Nov; 80(6):1239-61. PubMed ID: 8941222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.
    Mori K; Yasutomi Y; Sawada S; Villinger F; Sugama K; Rosenwith B; Heeney JL; Uberla K; Yamazaki S; Ansari AA; Rübsamen-Waigmann H
    J Virol; 2000 Jul; 74(13):5747-53. PubMed ID: 10846052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiretroviral therapy for HIV infection.
    Fischl MA
    Hosp Pract (Off Ed); 1994 Jan; 29(1):43-8. PubMed ID: 8288688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral dynamics of HIV: implications for drug development and therapeutic strategies.
    Havlir DV; Richman DD
    Ann Intern Med; 1996 Jun; 124(11):984-94. PubMed ID: 8624066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can HIV replication be controlled?
    Cohen J
    Science; 1993 May; 260(5112):1257. PubMed ID: 8333877
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
    De Clercq E
    Biomed Pharmacother; 1996; 50(5):207-15. PubMed ID: 8949401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS pathogenesis: from models to viral dynamics in patients.
    Nowak MA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S1-5. PubMed ID: 8595501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.
    Barbour JD; Wrin T; Grant RM; Martin JN; Segal MR; Petropoulos CJ; Deeks SG
    J Virol; 2002 Nov; 76(21):11104-12. PubMed ID: 12368352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals.
    Cohen OJ; Pantaleo G; Schwartzentruber DJ; Graziosi C; Vaccarezza M; Fauci AS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S6-14. PubMed ID: 8595512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
    Coffin JM
    Science; 1995 Jan; 267(5197):483-9. PubMed ID: 7824947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
    Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
    J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular virology and immunology of HIV infection.
    Chinen J; Shearer WT
    J Allergy Clin Immunol; 2002 Aug; 110(2):189-98. PubMed ID: 12170257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can HIV infection be eradicated through use of potent antiviral agents?
    Josefsson L; Dahl V; Palmer S
    Curr Opin Infect Dis; 2010 Dec; 23(6):628-32. PubMed ID: 20847693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the therapy of HIV infection.
    Yarchoan R; Mitsuya H; Broder S
    Immunol Today; 1993 Jun; 14(6):303-9. PubMed ID: 8397771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
    Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.